Oncotarget has now been deemed as one of the most valuable peer review journals among the medical community. While the journal is dedicated to the specialty of oncology within the medical field, there are numerous areas of related research that physicians have been able to benefit from as readers of this journal. Those working in the medical field that desire to reach their goals, can seek out authorship within the journal and expect to be reviewed by their peers. Those who make contributions to Oncotarget must have validated research as well as the education behind them to back up their submission. The submissions are reviewed and the authors are profiled prior to their submission to ensure that they are suitable candidates for the journal. The main goal of this publication is to help authors with the impact of their research.
Additionally, Oncotarget is also comprised of a stellar editorial board that has multiple professionals published in this journal. This above board medical journal is accepting papers in numerous areas including Neuroscience, Endocrinology, Cardiology, Metabolism, Cell Biology, Pharmacology, and much more. There are also significant indicators that shed light on the popularity and growing trend of journals like Oncotarget. This is because there is a consistent rise in the impact factor in Thompson Reuter’s since 2011 pointing toward the success of Oncotarget.
There are numerous in-depth topics within cancer that have been submitted to Oncotarget and the number of related articles is growing as more researchers learn about this publication and what it has to offer to the medical community.
This journal was established in 2010 for the purpose of covering studies and any research that has been performed in regards to cancer. The editors-in-chief are two well-known and highly respected oncologists, Dr. Mikhail Blagosklonny and Dr. Adrei V. Gudkov from the Roswell Cancer Institute. Visit classroomvoices.org to read more about Mikhail.